0P00000N8D.F - T. Rowe Price Funds SICAV - Euro Corporate Bond Fund Z EUR
Frankfurt - Frankfurt Delayed Price. Currency in EUR
At close: 10:00PM CEST
Stock chart is not supported by your current browser
| Previous Close | 22.57 |
| YTD Return | N/A |
| Expense Ratio (net) | 0.00% |
| Category | N/A |
| Last Cap Gain | N/A |
| Morningstar Rating | ★★★★★ |
| Morningstar Risk Rating | Average |
| Sustainability Rating |
| Net Assets | N/A |
| Beta (5Y Monthly) | 0.87 |
| Yield | 0.00% |
| 5y Average Return | N/A |
| Holdings Turnover | 124.62% |
| Last Dividend | N/A |
| Average for Category | N/A |
| Inception Date | Dec 07, 2012 |
Simply Wall St.Insiders in Akoya Biosciences, Inc. (NASDAQ:AKYA) are down 7.8% on their US$882k purchase despite recent gains
Insiders who bought US$882k worth of Akoya Biosciences, Inc. ( NASDAQ:AKYA ) stock in the last year recovered part of...
GlobeNewswireAkoya Biosciences to Highlight Novel Spatial Transcriptomics Capabilities on PhenoCycler-Fusion at AGBT 2022 Annual Meeting
PhenoCycler™-Fusion will enable single-cell, whole-slide spatial multiomic capabilities on a single platformMARLBOROUGH, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, will present for the first time, data generated using its proprietary RNA chemistry, which enables whole-slide spatial multiomics at single-cell resolution on the PhenoCycler-Fusion system, at the Advances in Genome Biology and Technology (AGBT) conference in Orlando